Grifols
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
79 Tw Alexander Dr, Durham, North Caroli...Phone Number
(888) 694-2686Website
www.gamunex-c.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
1
1
1
1
1
About Grifols
Grifols specializes in the development and distribution of GAMUNEX-C, an intravenous immunoglobulin therapy designed for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP). The product aims to improve symptoms, prevent nerve damage, and reduce the likelihood of relapse in patients suffering from CIDP. Grifols targets both patients and healthcare professionals, providing educational resources and support for effective management of CIDP. The company is committed to ensuring patient safety and offers financial assistance through Gamunex Connexions.Explore more
Grifols Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Grifols your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Grifols
Check out if Grifols is spiking on competitors!
Product Launch: Get notified when Grifols launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Grifols has new funding data
Earning: See what the market has to say on Grifols recently announced quarterly report
Check if Grifols has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Grifols, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Grifols had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Grifols
Find 3 more new buyers
Compare Similar Companies to Grifols
Compare insights from companies similar to Grifols, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Grifols is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Grifols is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Grifols.
Grifols Tech Stack
A closer look at the technologies used by Grifols
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Grifols
Sign Up For FreeTo access detailed company insights
Grifols specializes in the development and distribution of GAMUNEX-C, an intravenous immunoglobulin therapy designed for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP). The product aims to improve symptoms, prevent nerve damage, and reduce the likelihood of relapse in patients suffering from CIDP. Grifols targets both pat... Read More
